Literature DB >> 28303529

Lung cancer and β-glucans: review of potential therapeutic applications.

Raheleh Roudi1, Shahla Roudbar Mohammadi2, Maryam Roudbary3, Monireh Mohsenzadegan4.   

Abstract

The potential of natural substances with immunotherapeutic properties has long been studied. β-glucans, a cell wall component of certain bacteria and fungi, potentiate the immune system against microbes and toxic substances. Moreover, β-glucans are known to exhibit direct anticancer effects and can suppress cancer proliferation through immunomodulatory pathways. Mortality of lung cancer has been alarmingly increasingly worldwide; therefore, treatment of lung cancer is an urgent necessity. Numerous researchers are now dedicated to using β-glucans as a therapy for lung cancer. In the present attempt, we have reviewed the studies addressing therapeutic effects of β-glucans in primary and metastatic lung cancer published in the time period of 1991-2016.

Entities:  

Keywords:  Drug resistance; Immunomodulatory activity; Lung cancer; β-glucans

Mesh:

Substances:

Year:  2017        PMID: 28303529     DOI: 10.1007/s10637-017-0449-9

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  88 in total

Review 1.  Physical activity and cancer prevention: etiologic evidence and biological mechanisms.

Authors:  Christine M Friedenreich; Marla R Orenstein
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

2.  Orally administered marine (1-->3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity.

Authors:  Vaclav Vetvicka; Bohuslav Dvorak; Jana Vetvickova; Jan Richter; Jiri Krizan; Petr Sima; Jean-Claude Yvin
Journal:  Int J Biol Macromol       Date:  2006-08-23       Impact factor: 6.953

3.  Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55.

Authors:  Bing Li; Daniel J Allendorf; Richard Hansen; Jose Marroquin; Daniel E Cramer; Claire L Harris; Jun Yan
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

4.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins.

Authors:  Neil C Rogers; Emma C Slack; Alexander D Edwards; Martijn A Nolte; Oliver Schulz; Edina Schweighoffer; David L Williams; Siamon Gordon; Victor L Tybulewicz; Gordon D Brown; Caetano Reis e Sousa
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

Review 5.  Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization.

Authors:  Virginia Tirino; Vincenzo Desiderio; Francesca Paino; Alfredo De Rosa; Federica Papaccio; Marcella La Noce; Luigi Laino; Francesco De Francesco; Gianpaolo Papaccio
Journal:  FASEB J       Date:  2012-09-28       Impact factor: 5.191

6.  Wound healing efficacy of a chitosan-based film-forming gel containing tyrothricin in various rat wound models.

Authors:  Ju-Young Kim; Joon-Ho Jun; Sang-Joon Kim; Kyu-Mok Hwang; Sung Rak Choi; Sang Duk Han; Mi-Won Son; Eun-Seok Park
Journal:  Arch Pharm Res       Date:  2014-04-10       Impact factor: 4.946

Review 7.  Fungal beta-glucans and mammalian immunity.

Authors:  Gordon D Brown; Siamon Gordon
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

8.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

9.  Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy.

Authors:  Michael Driscoll; Richard Hansen; Chuanlin Ding; Daniel E Cramer; Jun Yan
Journal:  Cancer Biol Ther       Date:  2009-02-03       Impact factor: 4.742

10.  Characterization and optimization of the glucan particle-based vaccine platform.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Charles A Specht; Stuart M Levitz
Journal:  Clin Vaccine Immunol       Date:  2013-08-14
View more
  6 in total

1.  MiRNA505/NET1 Axis Acts as a CD8+ T-TIL Regulator in Non-Small Cell Lung Cancer.

Authors:  Pengyuan Zhu; Zhenchuan Liu; Haitao Huang; Chongjun Zhong; Yongxin Zhou
Journal:  Onco Targets Ther       Date:  2020-10-01       Impact factor: 4.147

Review 2.  Overview of β-Glucans from Laminaria spp.: Immunomodulation Properties and Applications on Biologic Models.

Authors:  Patrícia de Souza Bonfim-Mendonça; Isis Regina Grenier Capoci; Flávia Kelly Tobaldini-Valerio; Melyssa Negri; Terezinha Inez Estivalet Svidzinski
Journal:  Int J Mol Sci       Date:  2017-09-06       Impact factor: 5.923

3.  Bread for the Aging Population: The Effect of a Functional Wheat-Lentil Bread on the Immune Function of Aged Mice.

Authors:  Marina Carcea; Valeria Turfani; Valentina Narducci; Alessandra Durazzo; Alberto Finamore; Marianna Roselli; Rita Rami
Journal:  Foods       Date:  2019-10-18

Review 4.  Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers.

Authors:  Shruti Rawal; Mayur Patel
Journal:  Nanomicro Lett       Date:  2021-06-12

5.  Development and Evaluation of Multifunctional Poly(Lactic-co-glycolic acid) Nanoparticles Embedded in Carboxymethyl β-Glucan Porous Microcapsules as a Novel Drug Delivery System for Gefitinib.

Authors:  Xiaonan Li; Jinglei Wang; Shang Li; Zhaorong Liu; Zhiru Zheng; Yanzhuo Zhang
Journal:  Pharmaceutics       Date:  2019-09-12       Impact factor: 6.321

6.  Analysis of the control mechanism of lung cancer of caspase recruitment domain-containing protein 9 and myeloid-derived suppressor cell in Lewis lung cancer mice model.

Authors:  Xiaowei Wu; Fan Li; Yu Deng; Xiaowu Fan
Journal:  Saudi J Biol Sci       Date:  2019-09-24       Impact factor: 4.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.